Immune thrombocytopenia (ITP) in a patient with relapsing-remitting multiple sclerosis (RRMS) associated with b-interferon-1α treatment

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

This paper reports a case of severe immunethrombocytopenia (ITP) associated with b-interferon-1α (Cinnovex) in a patient with relapsing remitting multiples clerosis (RRMS). A 22 year old woman with a one-year history of RRMS referred to MS Clinic due to purpuricrash. The platelet count was 6,000/μL at admission.A diagnosis ITP was made. Cinnovex was stopped. She received intravenous methylprednisolone 500mg/d, for2days, and intravenous immungloboulin (IVIG), 55mg.Thrombocytopeniare solved in the following days. She was started on CinnoMer (GlatiramerAcetate, CinnaGenCo.) for MSmanagement.There was no recurrence of thrombocytopenia in the next follow-up visits.

Cite

CITATION STYLE

APA

Shaygannejad, V., Fayyazi, E., Mirmosayyeb, O., & Toghianifar, N. (2018). Immune thrombocytopenia (ITP) in a patient with relapsing-remitting multiple sclerosis (RRMS) associated with b-interferon-1α treatment. Indian Journal of Pharmaceutical Education and Research, 52(3), 540–542. https://doi.org/10.5530/ijper.52.3.62

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free